Electromed (ELMD) Revenue Growth (3y) (2013 - 2026)
Electromed (ELMD) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | 0.73% |
| 10 | Electromed | 326.89 Mn | 309.90 Mn | 14.64 Mn | 15.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.46% |
| Dec 31, 2025 | 17.23% |
| Sep 30, 2025 | 16.58% |
| Jun 30, 2025 | 15.57% |
| Mar 31, 2025 | 15.64% |
| Dec 31, 2024 | 16.62% |
| Sep 30, 2024 | 13.62% |
| Jun 30, 2024 | 16.14% |
| Mar 31, 2024 | 16.44% |
| Dec 31, 2023 | 12.96% |
| Sep 30, 2023 | 15.47% |
| Jun 30, 2023 | 25.55% |
| Mar 31, 2023 | 11.34% |
| Dec 31, 2022 | 11.13% |
| Sep 30, 2022 | 8.68% |
| Jun 30, 2022 | 9.41% |
| Mar 31, 2022 | 11.04% |
| Dec 31, 2021 | 8.55% |
| Sep 30, 2021 | 11.19% |
| Jun 30, 2021 | 6.35% |